Jan Debruyne

Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study

Ludwig Kappos, Amit Bar‐Or, Bruce Cree et al. · The Lancet · 2018 · 896 citations

Neurological Disorder, Clinical Neurology, Clinical Trials +9

PET visualization of microglia in multiple sclerosis patients using [¹¹C]PK11195

Jan Debruyne, Jan Versijpt, K. J. Van Laere et al. · European Journal of Neurology · 2003 · 215 citations

Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)

W. Oliver Tobin, Yong Guo, Karl N. Krecke et al. · Brain · 2017 · 194 citations · Full text

Inflammation, Spinal Cord Injury, Autoimmune Disease +15

Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study

Jan Versijpt, Jan Debruyne, K. J. Van Laere et al. · Multiple Sclerosis Journal · 2005 · 120 citations

Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis

Dirk De Ridder, Frank Van der Aa, Jan Debruyne et al. · Clinical Neurology and Neurosurgery · 2013 · 55 citations

Urology, Neurological Disorder, Clinical Neurology +6